Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Teratocarcinoma

2-amino-5-phosphonovalerate has been researched along with Teratocarcinoma in 2 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Teratocarcinoma: A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Görtz, P1
Fleischer, W1
Rosenbaum, C1
Otto, F1
Siebler, M1
Munir, M1
Lu, L1
Mcgonigle, P1

Other Studies

2 other studies available for 2-amino-5-phosphonovalerate and Teratocarcinoma

ArticleYear
Neuronal network properties of human teratocarcinoma cell line-derived neurons.
    Brain research, 2004, Aug-20, Volume: 1018, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Axons; Biomarkers; Brain Tissue Transplanta

2004
Excitotoxic cell death and delayed rescue in human neurons derived from NT2 cells.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1995, Volume: 15, Issue:12

    Topics: 2-Amino-5-phosphonovalerate; Cell Death; Cellular Senescence; Dizocilpine Maleate; Glutamic Acid; Hu

1995